Skip to main content
Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · S2P ISIN · HK0000658531 HKEX Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2021-11-01 Declaration of Voting R…
Country CN China
Listing HKEX S2P

About Simcere Pharmaceutical Group Limited

https://www.simcere.com/en/

Simcere Pharmaceutical Group Limited is an R&D-driven pharmaceutical company specializing in the discovery, development, and commercialization of innovative and branded generic prescription drugs. The company strategically focuses on core therapeutic areas, including neuroscience, anti-oncology, and inflammatory diseases. Simcere emphasizes synergistic innovation, evidenced by its development and launch of multiple Category I innovative pharmaceuticals and its strategic collaborations with global partners to advance novel treatments. These partnerships aim to address significant unmet medical needs and expand the company's portfolio across specialized disease areas.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 1, 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on November 1, 2021. It details the voting outcomes on various resolutions related to the grant of Restricted Stock Units (RSUs) under the 2021 RSU Scheme. The text includes specific vote counts and percentages for each resolution and confirms that the resolutions were passed. There is no detailed financial data, management discussion, or full report content. The document serves as an official disclosure of voting results rather than a full report or presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (6901 characters) and content confirm it is not merely a brief notice but a full announcement of voting results.
2021-11-01 English
Notification Letter and Request Form to Non-registered Shareholders
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated October 12, 2021, from Simcere Pharmaceutical Group Limited to non-registered shareholders. It informs recipients about the publication of a circular and notice of an Extraordinary General Meeting (EGM) and provides instructions on how to request printed versions of current and future corporate communications. The document includes a request form for shareholders to specify their preferred language and format for receiving corporate communications. It explicitly states that corporate communications include directors' reports, annual financial statements with auditors' reports, interim reports, notices of meetings, listing documents, circulars, and proxy forms. The document does not contain any financial data, analysis, or detailed report content itself but serves as a notification and request form related to the distribution of such documents. It is relatively short (7,385 characters) and functions as an announcement of the availability of other reports and communications rather than the reports themselves. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA).
2021-10-11 English
PROXY FORM FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON NOVEMBER 1, 2021
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for an Extraordinary General Meeting (EGM) of Simcere Pharmaceutical Group Limited, scheduled for November 1, 2021. It contains instructions for shareholders to appoint proxies and vote on specific resolutions related to the grant of restricted share units (RSUs) under a share scheme. The content is procedural and related to shareholder voting rather than financial results, management changes, or report publication. It is not a report itself but a form used to facilitate voting at a shareholder meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length (7979 characters) supports it being a detailed proxy form rather than a brief announcement or a full report.
2021-10-11 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Simcere Pharmaceutical Group Limited. It details the date, time, location, and agenda of the EGM, specifically the approval of restricted share units (RSUs) grants to various individuals under a share unit scheme. The document includes procedural notes about voting, proxy appointments, and COVID-19 measures for the meeting. There are no financial statements, management discussion, or detailed financial data present. The document is a formal meeting notice rather than a report or results announcement. Therefore, it fits the category of a meeting notice related to shareholder voting and resolutions, which aligns with the category "Declaration of Voting Results & Voting Rights Announcements (DVA)" or possibly "Proxy Solicitation & Information Statement (PSI)". However, since this document is a notice of the meeting itself and not the solicitation materials or proxy statement, and it is not the voting results announcement either, it is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of the meeting and resolutions to be voted on, but not the results or proxy solicitation materials. The document length (8453 characters) and content confirm it is a full notice, not a brief announcement or proxy statement. Hence, the best fit is Regulatory Filings (RNS).
2021-10-11 English
CONNECTED TRANSACTIONS IN RELATION TO THE PROPOSED GRANT OF RSUS TO THE CONNECTED GRANTEES AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Simcere Pharmaceutical Group Limited regarding connected transactions related to the proposed grant of restricted share units (RSUs) to connected grantees and includes a notice of an Extraordinary General Meeting (EGM). It contains detailed definitions, letters from the Board, Independent Board Committee, and Independent Financial Adviser, as well as a notice of the EGM and proxy form. The content is focused on corporate governance matters related to shareholder approval of transactions involving connected persons. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes for the EGM resolutions. It is not an annual or interim report, earnings release, or a simple announcement. The length and detailed content confirm it is the full circular, not just a report publication announcement or regulatory filing. Therefore, the appropriate classification is PSI with high confidence.
2021-10-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 September 2021. It details movements in issued shares, share options, and other share-related information for Simcere Pharmaceutical Group Limited. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share movements for a specific month. It does not contain financial statements, earnings data, or management discussion. It is a regulatory filing related to share capital movements and compliance with listing rules, not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS).
2021-10-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.